The acute-phase reactant C-reactive protein (CRP) increases rapidly during an infection. We tested the hypothesis that chronic low-level increases in CRP are associated with an increased risk of infectious disease.
with infectious disease; tumor necrosis factor-␣ (6, 7 ) and IL-1 (8 ) , for example, have been associated with susceptibility to sepsis. But for CRP polymorphisms and haplotypes known to affect CRP concentrations (4, 9 -12 ) , there has been only inconsistent association with pneumonia (13 ) , mortality from sepsis with Streptococcus pneumoniae infection (14, 15 ) , and Plasmodium falciparum malaria (16 ) . Two small studies with 200 and 50 participants have associated low-level increased CRP plasma concentrations with risk of infections (17, 18 ) . Collectively, these studies suggest that, whereas upregulation of CRP is important in response to infection, lowlevel increases in CRP may be associated with increased risk of infectious disease.
Here, we tested the hypothesis that chronic low-level increases in CRP are associated with an increased risk of infectious disease. We investigated this for overall infection and for infectious subgroups in 2 large general population cohorts. One was a prospective study including 9660 participants with Ͼ30 years of follow-up, and the other was a cross-sectional study including Ͼ60 896 participants.
Materials and Methods
The studies were approved by Herlev Hospital and Danish ethics committees (KF-100.2039/91, H-KF-01-144/ 01) and were conducted according to the Declaration of Helsinki. Written informed consent was obtained from participants. The study was designed and conducted by the authors and funded by the Danish Heart Foundation and Herlev Hospital.
The 2 cohorts we studied included white individuals of Danish descent and were independent of each other. No individual appears twice in any of the analysis groups, thus permitting independent confirmation of findings in each group and allowing for the combination of the 2 cohorts.
STUDY COHORTS
The Copenhagen City Heart Study (19, 20 ) is a prospective study of a cohort of individuals randomly selected from the population of the City of Copenhagen. From this study, 9960 participants were included in the present analysis (participation rate 61%).
The Copenhagen General Population Study (19, 21 ) is a cross-sectional study of individuals selected similarly to those in the Copenhagen City Heart Study, but from the population of the suburbs of Copenhagen. From this study, we included 60 896 participants in the present analysis (participation rate 44%).
For both studies, end points with regard to infectious diseases were based on the WHO International Classification of Diseases, eighth and 10th revisions (ICD-8 and ICD-10), and information on morbidity causing hospitalization was drawn from the national Danish Patient Registry (data from study inclusion to May 9, 2009 , were available) (22 ) . Infectious diseases were classified as bacterial, viral, or other. Bacterial diseases: diarrheal, 000 -001, 004 -006, 008 -009, A00 -A01, A03-A04, A06 -A09; meningitis, 320, A39.0, G00 -G03; pneumonia, 480 -486, A48.1, J12-J18; sepsis, 036.1, 038, A32.7, A39.2-4, A40 -41, A48.3; skin infection, 680 -686, A46, L00 -L08; tuberculosis, 010 -018, A15-A19, B90; and urinary tract infection, 590, 595, N10 -12, N30. Viral diseases: HIV/AIDS, 137, B20 -B24; hepatitis, 070, B15-B19; and other viral, 040 -061, 075, 079, B00 -B09, B25-B34. Other infections: mycoses, 110 -112, 114 -117, B35-B49; and parasitic infection, B50 -B64. Infectious disease events obtained through ICD codes had been validated previously (23 ) .
Information on mortality and infectious diseases stated as a contributing cause until August 17, 2010, was available from the national Danish Civil Registration System and the national Danish Causes of Death Registry. For morbidity and mortality, no one was lost to follow-up.
GENOTYPING AND BIOCHEMICAL ANALYSES

ABI Prism
® 7900HT SDS (Applied Biosystems) was used to genotype for 4 single nucleotide polymorphisms in the CRP gene (rs3091244, rs1130864, rs1205, and rs3093077) (24 ) . Genotyping was verified by DNA sequencing in Ͼ30 individuals with each genotype. CRP was measured with high-sensitivity nephelometry or turbidimetry assays.
COVARIATES
Covariates for adjustments were chosen on the basis of known influence on plasma CRP concentrations or risk of infection. Body mass index was expressed as measured weight in kilograms divided by measured height in meters squared. Diabetes mellitus was nonfasting blood glucose concentrations Ն198 mg/L (Ն11.0 mmol/L) or use of insulin or oral antidiabetic treatment. Smokers were current and former smokers combined. Alcohol intake was based on average weekly consumption of beer, wine, and liquor in units: 1 U alcohol ϭ approximately 12 g. Lipid-lowering therapy was mainly statins. Plasma cholesterol concentration was measured with standard hospital assays. Information on cancer was from the national Danish Cancer Registry (25 ) .
STATISTICAL ANALYSES
We used Stata 10.1 for all analyses. We excluded all individuals with plasma CRP concentrations Ͼ10 mg/L, because they may have had ongoing infection at the time of testing. For trend tests, the different groupings of individuals were coded 1, 2, 3, etc. From the 4 CRP polymorphisms, we generated all possible genotype combinations and ranked the 9 most common combinations according to increasing plasma CRP concentrations.
We analyzed the relationship between CRP plasma concentrations, CRP genotype, and genotype combinations and risk of infectious disease in the prospective Copenhagen City Heart Study, with the use of left truncation (or delayed entry) (from the 1976 -78 examination) (26 ) . Cox regression models with age as the time scale were used to estimate hazard ratios (HRs) with 95% CIs for infectious disease. Results were confirmed in the cross-sectional Copenhagen General Population Study (4 ) by use of a logistic regression model with inclusion of infectious disease events both before and after CRP measurement. Combined analyses of the cohorts were performed to increase statistical power.
Results
Baseline characteristics of the 2 cohorts are given in Table  1 . Of all individuals, 55% were women, and the mean age was 57 years. Individuals hospitalized for an infection were older and had more risk factors in terms of diabetes and smoking than individuals never hospitalized for infectious disease. There were marginal but statistically significant differences for sex, BMI, alcohol intake, and previous cancer diagnosis. Total cholesterol concentrations in the Copenhagen City Heart Study were higher in those having an infection vs those who had not: 228 (197-259) and 212 (185-247) mg/dL, respectively. This was not seen in the Copenhagen General Population Study (Table 1) . Glucose concentrations were also increased in the Copenhagen City Heart Study for those with an infection vs those without. This was not seen in the Copenhagen General Population study (Table 1) .
Individuals were divided in 3 groups on the basis of plasma CRP concentrations (Ͻ1, 1-3, or Ͼ3 mg/L); individuals with CRP Ͼ10 mg/L were excluded because they may have had ongoing infection at the time of testing. With increasing CRP concentrations, there was a consistent and significant trend toward an increased risk of being hospitalized with an infection, in both the prospective Copenhagen City Heart Study and the crosssectional Copenhagen General Population Study (Fig.  1 ). In the Copenhagen City Heart Study, the age-and sex-adjusted risk in those with CRP Ͼ3 vs Ͻ1 mg/L was increased 20% (HR 1.2; 95% CI, 1.0 -1.4), and in the Copenhagen General Population Study, the corresponding risk was increased 70% [odds ratio (OR) 1.7; 95% CI, 1.6 -1.8) (Fig. 1) . After multifactorial adjustment for the covariates in Table 1 , the association for the Copenhagen City Heart Study was no longer statistically significant; however, it remained highly statistically significant after such adjustment in the much larger Copenhagen General Population Study. Similar consistent and significant trends were seen when combining the 2 studies and when dividing the participants in tertiles or octiles (P Ͻ 0.001) (Fig. 2 , left panels). After removing those who were hospitalized with infections within the first year after measurement of CRP concentrations (to exclude individuals with an occult infectious disease at the time of CRP measurement), the results were similar (Fig. 2 , right panels). Infectious disease hospitalizations were further divided into bacterial, viral, or other causes. An analysis of CRP tertiles showed a 70% (HR 1.7; 95% CI, 1.6 -1.8) increased risk of bacterial infection for the highest compared to the lowest tertile (Fig. 3) . In contrast, for viral infections and for other infections, there was no increased risk associated with increased CRP tertiles (Fig. 3) .
Bacterial infections were then subdivided, and the association with CRP remained significant for each bacterial infection studied (Fig. 4) . The highest ORs associated with CRP upper vs lower tertile were for pneumonia, with 2.1 (95% CI, 2.0 -2.3), and for sepsis, with 2.2 (95% CI, 1.9 -2.5). None of the viral and other infections were associated with an increased risk as a function of increasing CRP tertiles (Fig. 4) .
Because CRP concentrations may differ for gramnegative and -positive bacterial infections, we also analyzed them separately for pneumonia and sepsis. The increase in risk associated with CRP upper vs lower tertiles Hazard ratio for risk of infection (95% CI) Odds ratio for risk of infection (95% CI) Individuals with CRP >10 mg/L were excluded because they may have had ongoing infection at the time of testing. Multifactorial adjustment included all covariates listed in Table 1 .
Infectious disease that occurred within 1 year excluded Participants from the Copenhagen City Heart Study and the Copenhagen General Population Study were combined to achieve maximal statistical power. Hospitalizations within 1 year after baseline measurement of P-CRP were not included in the analysis on the rightside panel to exclude individuals with an occult infectious disease at the time of the CRP measurement. Multifactorial adjustment included all covariates listed in Table 1 .
was evident only for gram-negative pneumonia, with an OR of 2.8 (95% CI, 1.5-5.0), whereas the corresponding value for gram-positive pneumonia was 1.4 (95% CI, 0.9 -2.2) (Fig. 5) . Similarly, for sepsis, the corresponding risk was greater for gram-negative bacteria (OR 2.4; 95% CI, 1.6 -3.5) compared with gram-positive bacteria (OR 1.6; 95% CI, 1.0 -2.4) (Fig. 5) . For urinary infections, the risk for cystitis (OR 1.8; 95% CI, 1.6 -1.9) was higher compared with the risk for pyelonephritis (OR 1.3; 95% CI, 1.0 -1.7) (Fig. 5) . Extrapulmonary tuberculosis, OR 3.5 (95% CI, 0.7-16.8), was associated with a higher risk compared with pulmonary infection, 1.4 (95% CI, 0.8 -2.4) (Fig. 5) . For skin infections, only a minor difference was seen between erysipelas/cellulitis and abscess (Fig. 5 ). Bacterial and viral diarrheal infections were analyzed separately and revealed only a small difference in risk (Fig. 5 ). Genotypes and genotype combinations were used to study whether there was any association between genotypes with a significant effect on CRP concentration and risk of infectious diseases. Genotypes were associated with plasma CRP concentrations (see Supplemental Fig.  1 , which accompanies the online version of this article at http://www.clinchem.org/content/vol62/issue2). CRP genotypes or genotype combinations were not associated with any of the risk factors (see online Supplemental Table 1 ). Assuming that increasing plasma CRP concentrations are causally related to increased risk of infections, then the 47% increase in plasma CRP concentrations for the ninth genotype combination compared to the first genotype combination would result in a 15% (HR 1.15; 95% CI, 1.10 -1.20) increased risk of infections (see online Supplemental Fig. 1 ). However, no increased risk was observed for the ninth genotype combination vs the first combination (see online Supplemental Fig. 1 ). The increased risk for the eighth genotype combination vs the first combination is believed to represent a chance finding on the basis of no increased risk when combining the genotype combination in groups with third through sixth and seventh through ninth vs the first combination, increasing the power to detect a difference.
Discussion
The principal novel finding of this study is that a chronic low-level increase in plasma CRP was associated with an increased risk of infection. Importantly, the increased risk was observed only for bacterial infections, and not for viral, mycosis, and parasitic diseases, and was most pronounced for gram-negative bacterial infections. In line with this, CRP concentrations have been reported to be higher in gramnegative vs gram-positive bacterial infections (27 ) .
To explain these findings, one theory could be that it was the chronically low-level increase in plasma CRP per se that caused the increased risk; however, this is unlikely, as in our 2 large studies with 10 000 and 60 000 partici- Participants from the Copenhagen City Heart Study and the Copenhagen General Population Study were combined to achieve maximal statistical power. Multifactorial adjustment included all covariates listed in Table 1 .
pants there was no effect on risk of infection for the different CRP genotypes or genotype combinations, all leading to lifelong higher CRP concentrations (4 ). If it is not the plasma CRP increase in itself that causes the increase in risk of infection, perhaps it is rather a different CRP response that affects the ability to counter infections. Others have shown that those homozygous for the CRP rs1130864 polymorphism have higher concentrations of plasma CRP in an endotoxemia state compared to wild-type carriers (11 ) . The CRP polymorphism should be associated with a higher CRP concentration and presumably also a different response rate to infections. Earlier, we have shown that the CRP rs1130864 polymorphism is associated with a higher CRP concentration in these 2 large general populations (4 ); however, here we did not find an association with risk of infectious disease. Concurrent with our findings, others were unable to show any association between single nucleotide polymorphisms in inflammatory pathways and disease severity in sepsis (28 ) . Further, humans deficient in the ability to synthesize CRP have never been reported, nor have mutations in the gene that would alter the amino acid sequence of the protein (29 ) . Together, these findings suggests that it is not the chronic increase in CRP concentrations per se nor the peak increase in plasma CRP concentrations that hinder infection.
Another explanation could be that chronic low-level inflammation being associated with chronic diseases and conditions (e.g., atherosclerosis, cancer, chronic obstructive pulmonary disease, and obesity (4, 30 -32 ) ) is associated with a poorer immune system. The explanation could be that chronic low-level inflammation makes it difficult to provide an adequate response-perhaps because of exhaustion, as there is a constant activity and therefore difficulty in scaling up the response when needed. Presumably, the magnitude of the plasma CRP response is not of importance. The crucial point is that a response is present in order for plasma CRP to interact in the innate and the adaptive immune system. It could be speculated that the chronic low-level increased plasma CRP concentration in noninfectious conditions is counteracted by a feedback system to make sure that the im- Odds ratio for infection (95% CI) Odds ratio for infection (95% CI) Participants from the Copenhagen City Heart Study and the Copenhagen General Population Study were combined to achieve maximal statistical power. Multifactorial adjustment included all covariates listed in Table 1 .
mune system does not give rise to inappropriate effects. It would be logical that the inflammatory response, without an infectious stimulus, is counterbalanced. Other explanations could be that in a chronic inflammatory state, perhaps the function of neutrophil leukocytes or macrophages are affected, or perhaps the effect of the chronic inflammation on the endothelium leads to a change in the extravasation of neutrophil leukocytes or altered leukocyte-endothelium interaction.
Strengths of the present study include recruitment of roughly 70 000 participants from a homogeneous population, detailed information on potential confounders, high participation rates, long follow-up time without losses to follow-up, and inclusion of CRP genotypes and genotype combinations to examine whether CRP increase per se is a cause of the increased risk of bacterial infection observed.
Some limitations of our study should be considered, since each of the 2 population cohorts have limitations and potential biases because of the different designs, although the results from these 2 cohorts were similar. Also, because the diagnoses are based on hospital discharge records or death certificates, not all events will be based on microbiological assessments. However, as the results are consistent for bacterial, viral, and other infections, we find this bias to be of less importance. Furthermore, as we studied whites only, our results may therefore not necessarily apply to other ethnic groups. On the other hand, we are not aware of data to suggest that our results should not be applicable to people of all or most races. Particularly for diarrheal infections, it is not likely that all diagnoses have been done on the basis of a microbiological sample assessment, and since these diagnosis are based on hospital discharge records, it is most likely that, given the severity of the events causing hospitalization, they are caused by bacteria. In support of this is the lack of difference between the bacterial and viral diarrheal infections, which is in contrast to the clear differences seen in Fig. 4 for bacterial and viral infections.
Future research should be directed at better understanding the mechanism behind the high risk of bacterial infection seen in individuals with chronic low-level increased CRP concentrations, and specifically whether repressive feedback mechanisms exist for CRP production in those with low-level increased CRP concentrations.
In conclusion, we find chronic low-level increased plasma CRP concentrations to be associated with an in- Participants from the Copenhagen City Heart Study and the Copenhagen General Population Study were combined to achieve maximal statistical power. Multifactorial adjustment included all covariates listed in Table 1 .
creased risk of bacterial infections, and in particular, gram-negative infections. However, genotypes associated with increases in plasma CRP concentrations were not associated with increased risk of infection.
